Solving cancer health disparities

Leaving no patient alone to access quality cancer care

Fostering stronger communication to all stakeholders

Critical Statistics

Cancer Screening

It saves lives and reduces the total cost of care during the lifetime of beneficiaries




Mammography

Close to 30% of women did not get a mammography to detect breast cancer between 2017-2019 despite it being most curable when caught in early stages


Prostate Cancer

African American males with prostate cancer, stomach cancer, or multiple myeloma have a 2 times higher likelihood of dying from prostate cancer compared to Caucasian male

Lung Cancer

Males living in Kentucky with lung cancer have a 3.5 times higher incidence and death rate compared to those living in Utah



Life Expectancy

 Person born and living in The French Quarter is 55 years compared to someone living in Navarre (less than 10 miles away), where life expectancy is 80 years



Lung Cancer Screenings

87% of eligible seniors do not receive lung cancer screenings




Who we are

We aim to address health disparities, improve access to healthcare and bring healthcare equity

No One Left Alone aims to address health disparities and improve access to care by carrying out research, educating the community, and recommending steps to bring healthcare equity

The No One Left Alone Foundation (the "Foundation") is a North Carolina not for profit 501C3 corporation. We raise funds for our activities through appeals to institutions, foundations, and individuals in the private sector – including pharmaceutical manufacturers, diagnostic laboratories, other corporations, and institutions involved in manufacturing and distribution of healthcare products. We are here to address cancer health disparities and promote population health amongst our aims.

Read More

What do we do?

Promulgate awareness

and promote education surrounding the steps to reduce barriers and increase access to equitable cancer care



Support local and national initiatives

that improve healthcare equity, and encourage efforts to track, measure, monitor and research steps that improve access to cancer care

Encourage the development and implementation

of steps that reduce cancer health disparities and bring initiatives that benefit the public health of the citizens of the United States of America

Sponsor, host and/or participate in events

and activities that promote better cancer care from prevention to survivorship







Promote education, research

and other charitable and scientific programs to increase awareness and financial support







Instruct or train individuals

on improvement and development of their capabilities in the instruction of the public on subjects useful and beneficial to the community through publications and public seminars and through the preparation and presentation of seminars and courses of study

Raise funding

from multiple stakeholders to support the mission of research, data analytics and implementation of steps to address healthcare disparities particularly in cancer






Why this is important?

Cancer health disparities are one of the foremost public health challenges in the United States. Racial and ethnic minority populations are among the most vulnerable U.S. population groups experiencing severe disparities when it comes to treatment for cancer. Although there has been some success in reducing cancer incidence and health disparities, the overall cancer death rates among racial and ethnic groups are less pronounced now than they have been in the past two decades. Disparities exist along the entire paradigm of cancer care in the US. From exposure to preventable cancer risk factors, rates of cancer screening for early detection, implementation of precision oncology, diagnostic testing, enrollment in clinical trials to receipt of standard of care cancer treatment the burden of the adverse effects of cancer and cancer treatment disproportionately fall on racial and ethnic minorities and the socioeconomically less fortunate, alongside other underserved populations in the United States. In addition, recent focus has identified a major role of multiple
social determinants of health (SDoH) Social Determinants of Health (SDoH) are defined as “the conditions in which people are born, grow, work, live, age and the wider set of forces and systems that shape the conditions of daily life”. They are responsible for most health inequalities as they affect factors at a local, national, and global level. We believe that understanding and addressing SDoH is a pressing issue for the entire ecosystem involved in the delivery of healthcare (including diagnostic companies involved in precision medicine, pharma manufacturers, CROs, policy makers, physicians, and medical professionals in the communities they serve). A health care delivery model that factors in the correlation between SDoH and the following factors will enable us to identify the role and influence of all individuals to figure out a path that will promote equity, equality, and justice for all.
adversely impacting cancer outcomes.

Our Goals

Improve SDoH Data Collection

Mandate the collection and reporting of key data elements to better understand the sub-populations and their health outcomes

Improve Access to Cancer Care

Increase access to cancer screening, extend clinic availability including after hours and on weekends, and reduce financial toxicities.

Improve Access to Testing and Therapies

Include appropriate biomarker testing. Leverage biomarker findings to select most appropriate treatment options. Lower costs though the use of generics and biosimilars

Increase in Clinical Trial Participation

Identify community clinics serving these patient populations. Provide customized patient materials to increase participation. Leverage real world evidence studies to better understand the impact of disparities on patient outcomes.

Our Pillar

Kashyap Patel, MD is the CEO of Carolina Blood and Cancer Care Associates and has built a practice with 8 providers. Dr. Patel is the President for the Community Oncology Alliance and regularly interacts with the US Congress, US Senate, and the White House on healthcare policy related issues for cancer patients. He is the consultant Medical Director for the BlueCross BlueShield of South Carolina as well as the Medical Director for the International Oncology Network. Dr. Patel is the author of ‘Between Life and Death’, a book published by Penguin Randomhouse India,www.betweenlifeanddeath.org.

Kashyap Patel, MD is the CEO of Carolina Blood and Cancer Care Associates and has built a practice with 8 providers. Dr. Patel is the President for the Community Oncology Alliance and regularly interacts with the US Congress, US Senate, and the White House on healthcare policy related issues for cancer patients. He is the consultant Medical Director for the BlueCross BlueShield of South Carolina as well as the Medical Director for the International Oncology Network. Dr. Patel is the author of ‘Between Life and Death’, a book published by Penguin Randomhouse India,www.betweenlifeanddeath.org.